Y-mabs therapeutics to present at 42nd annual j.p. morgan healthcare conference

New york, jan. 02, 2024 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced that michael rossi, president and chief executive officer, will present at the 42nd annual j.p. morgan healthcare conference in san francisco, ca on wednesday, january 10, 2024 at 5:15pm pt.
YMAB Ratings Summary
YMAB Quant Ranking